Page last updated: 2024-10-30

lansoprazole and Edema, Laryngeal

lansoprazole has been researched along with Edema, Laryngeal in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"In the dysphagia group, 48 of 54 patients (89%) had edema of the posterior larynx, and 42 of 54 (78%) had laryngopharyngeal sensory deficits."1.31Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia. ( Aviv, JE; Close, LG; Kaplan, ST; Liu, H; Parides, M, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pérez Roldán, F1
de los Ríos, IL1
Rodríguez Quinzaños, E1
Aviv, JE1
Liu, H1
Parides, M1
Kaplan, ST1
Close, LG1

Other Studies

2 other studies available for lansoprazole and Edema, Laryngeal

ArticleYear
Lansoprazole and glottis edema.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Drug Hypersensitivity; Humans; La

1999
Laryngopharyngeal sensory deficits in patients with laryngopharyngeal reflux and dysphagia.
    The Annals of otology, rhinology, and laryngology, 2000, Volume: 109, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Deglutition Disorders; Fema

2000